CIK 0000894556 · Chemicals & Allied Products (SIC 2800) · NYSE · incorporated in WY · fiscal year ends 12/31
| FY2024 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|
| Revenue (USD) | 520645 | 0 | ||
| Net income (USD) | -10.1 M | -94973 | -109355 | 0 |
| Diluted EPS (USD/shares) | -0.1 | 0 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-20 | EFFECT | EFFECT items ,, | |
| 2026-10-05 | 4 | 4 | 2025-10-01 |
| 2026-10-01 | S-1/A | AMENDMENT NO 1 | |
| 2026-09-28 | S-1 | REGISTRATION STATEMENT | |
| 2026-09-14 | 8-K | FORM 8-K items 1.01,7.01,9.01 | 2026-09-14 |
| 2026-08-28 | DRS | DRS | |
| 2026-08-10 | 10-Q/A | FORM 10-Q FOR JUN 2026, AMENDMENT 1 | 2026-06-30 |
| 2026-08-10 | 10-Q | FORM 10-Q FOR JUN 2026 | 2026-06-30 |
| 2026-08-06 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-08-06 | 4 | FORM 4 | 2026-08-04 |
| 2026-07-29 | 4 | FORM 4 | 2026-04-16 |
| 2026-07-21 | 3 | PRIMARY DOCUMENT | 2026-06-17 |
| 2026-06-17 | 8-K | FORM 8-K items 5.02 | 2026-06-12 |
| 2026-06-12 | 4 | 4 | 2026-03-16 |
| 2026-06-05 | 4 | 4 | 2026-03-16 |
| 2026-06-03 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-06-03 | S-8 | REGISTRATION STATEMENT | |
| 2026-06-01 | 4 | 4 | 2026-05-28 |
| 2026-06-01 | 3 | 3 | 2025-10-15 |
| 2026-06-01 | 4 | 4 | 2026-05-28 |
| 2026-06-01 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-06-01 | 8-K | FORM 8-K items 1.01,3.02,9.01 | 2026-05-28 |
| 2026-05-15 | 10-Q | FORM 10-Q FOR MAR 2026 | 2026-03-31 |
| 2026-05-05 | DEF 14C | FORM DEF14C | 2026-05-25 |
| 2026-04-30 | 4 | 4 | 2026-04-07 |
Forms on file (last 1,000): 8-K 67, 10-Q 60, 5 35, 10QSB 31, 4 24, 3 19, 10-K 19, NT 10-Q 18. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=CITR (0.002 USD), /gw/filings/filings?ticker=CITR&form=8-K, /gw/filings/facts?ticker=CITR&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange